Cumberland Pharmaceuticals (CPIX) Gross Profit Growth (3y) (2013 - 2026)
Cumberland Pharmaceuticals (CPIX) Gross Profit Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 7.62% |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn | 4.71% |
| 4 | Takeda Pharmaceutical | 27.53 Bn | 23.47 Bn | 4.39 Bn | -7.64% |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn | 12.55% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.32 Bn | 18.52 Bn | 1.16 Bn | -9.13% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 24.80% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 0.95% |
| 10 | Cumberland Pharmaceuticals | 101.43 Mn | 90.42 Mn | 7.20 Mn | -3.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.36% |
| Dec 31, 2025 | 20.89% |
| Sep 30, 2025 | -7.37% |
| Jun 30, 2025 | 2.20% |
| Mar 31, 2025 | 4.70% |
| Dec 31, 2024 | 19.20% |
| Sep 30, 2024 | 4.80% |
| Jun 30, 2024 | 3.62% |
| Mar 31, 2024 | -5.18% |
| Dec 31, 2023 | -0.72% |
| Sep 30, 2023 | 5.39% |
| Jun 30, 2023 | 10.26% |
| Mar 31, 2023 | 5.99% |
| Dec 31, 2022 | -2.18% |
| Sep 30, 2022 | 19.72% |
| Jun 30, 2022 | 2.73% |
| Mar 31, 2022 | 8.22% |
| Dec 31, 2021 | -25.32% |
| Sep 30, 2021 | -1.38% |
| Jun 30, 2021 | -5.40% |